1. Home
  2. BLCO vs ACT Comparison

BLCO vs ACT Comparison

Compare BLCO & ACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • ACT
  • Stock Information
  • Founded
  • BLCO 1853
  • ACT 1981
  • Country
  • BLCO Canada
  • ACT United States
  • Employees
  • BLCO N/A
  • ACT N/A
  • Industry
  • BLCO Ophthalmic Goods
  • ACT Specialty Insurers
  • Sector
  • BLCO Health Care
  • ACT Finance
  • Exchange
  • BLCO Nasdaq
  • ACT Nasdaq
  • Market Cap
  • BLCO 4.4B
  • ACT 5.1B
  • IPO Year
  • BLCO 2022
  • ACT 2021
  • Fundamental
  • Price
  • BLCO $11.70
  • ACT $36.28
  • Analyst Decision
  • BLCO Hold
  • ACT Buy
  • Analyst Count
  • BLCO 13
  • ACT 4
  • Target Price
  • BLCO $15.63
  • ACT $37.75
  • AVG Volume (30 Days)
  • BLCO 578.9K
  • ACT 412.8K
  • Earning Date
  • BLCO 07-30-2025
  • ACT 07-30-2025
  • Dividend Yield
  • BLCO N/A
  • ACT 2.32%
  • EPS Growth
  • BLCO N/A
  • ACT 9.98
  • EPS
  • BLCO N/A
  • ACT 4.44
  • Revenue
  • BLCO $4,829,000,000.00
  • ACT $1,216,974,000.00
  • Revenue This Year
  • BLCO $6.97
  • ACT $4.51
  • Revenue Next Year
  • BLCO $5.48
  • ACT $4.46
  • P/E Ratio
  • BLCO N/A
  • ACT $8.16
  • Revenue Growth
  • BLCO 11.94
  • ACT 4.52
  • 52 Week Low
  • BLCO $10.45
  • ACT $29.97
  • 52 Week High
  • BLCO $21.69
  • ACT $37.56
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 45.65
  • ACT 58.24
  • Support Level
  • BLCO $11.44
  • ACT $34.77
  • Resistance Level
  • BLCO $12.70
  • ACT $36.40
  • Average True Range (ATR)
  • BLCO 0.36
  • ACT 0.70
  • MACD
  • BLCO 0.01
  • ACT 0.14
  • Stochastic Oscillator
  • BLCO 30.07
  • ACT 95.10

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About ACT Enact Holdings Inc.

Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The principal mortgage insurance customers are originators of residential mortgage loans who determine which mortgage insurer or insurers will be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.

Share on Social Networks: